Scancell Holdings plc is a United Kingdom biotechnology company focused on developing immunotherapies and vaccines for cancer and infectious disease. Its pipeline is based on antibody and vaccine platforms designed to stimulate or enhance immune responses.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!